Figure 6.

No changes in fasting glucose levels after chronic fluoxetine (fluox, 10 mg/kg) and olanzapine (olanz, 5 mg/g or 0.5 mg/kg) dosing. Rats under the depicted drug regimens did not show overt differences in glucose metabolism. Data represent means ± SEM. N = 5–7 animals per group. NS = not significant. Non-fasting glucose levels in rats are typically in the range of 155–242 mg/dL.